Delivery Order SPE2DB20D9331-SPE2DB24FL1P7

Award Date 8/13/24
Potential Completion Date 9/4/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,662.16 firm fixed-price delivery order is for the supply of Lenvima 10 mg daily dose prescriptions, a specialized medication used to treat certain types of cancer. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award, valued at $33,020.85, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, awarded under the DLA's SPE2DB program, a multi-award indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 for pharmaceutical products to support the recurring medical supply...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 10 mg daily dose 30s, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,013.90 firm fixed-price delivery order is for the supply of Lenvima 8 mg daily dose 60s, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,324.32 contract is for the supply of Lenvima 10 mg daily dose 30s, a medication used in the treatment of certain types of cancer. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award, valued at $22,013.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product Lenvima 20mg daily 60s, a treatment used for certain types of cancer. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order worth $11,006.95 for the supply of LENVIMA 10 MG DAILY DOSE 30S, with a period of performance through October 28, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 10 mg daily dose medication. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA valued at up to $499,999,999, which runs through December 31, 2025. The IDC covers a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,013.90 firm fixed-price delivery order is for the supply of LENVIMA 12 MG DAILY DOSE 90S, a specialized pharmaceutical product. The award is not associated with a set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award, valued at $11,006.95, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of LENVIMA 4 MG CAPSULE 30S, a pharmaceutical product, and has a completion date of June 10, 2024. The award is a delivery order under a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL1P7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 firm fixed-price delivery order is for the supply of Lenvima 10 mg daily dose 30s, a medication used to treat certain types of cancer.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation. Through this vehicle and other prime vendor contracts, DMS Pharmaceutical Group solidifies its position as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to Department of Defense healthcare facilities.

Generated 1/9/25, 9:29 AM